Roberto Cuca - 29 Nov 2021 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
COO and CFO
Signature
/s/ Roberto Cuca
Issuer symbol
TELA
Transactions as of
29 Nov 2021
Net transactions value
+$38,245
Form type
4
Filing time
01 Dec 2021, 19:25:02 UTC
Previous filing
29 Sep 2021
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Purchase $5,330 +423 $12.60 423 29 Nov 2021 Direct F1
transaction TELA Common Stock Purchase $10,416 +838 +198% $12.43 1,261 30 Nov 2021 Direct F2
transaction TELA Common Stock Purchase $22,499 +1,780 +141% $12.64 3,041 01 Dec 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.41 to $12.74. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.40 to $12.49. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.55 to $12.65. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.